PNC Financial Services Group
CORT icon

PNC Financial Services Group’s Corcept Therapeutics CORT Stock Holding History

PNC Financial Services Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Buy
22,260
+3,230
+17% +$195K ﹤0.01% 1074
2026
Q1 		$767K Buy
19,030
+1,455
+8% +$54.4K ﹤0.01% 1429
2025
Q4 		$612K Buy
17,575
+2,775
+19% +$218K ﹤0.01% 1515
2025
Q3 		$1.23M Buy
14,800
+1,529
+12% +$111K ﹤0.01% 1145
2025
Q2 		$974K Buy
13,271
+81
+0.6% +$5.87K ﹤0.01% 1202
2025
Q1 		$1.51M Buy
13,190
+2,584
+24% +$157K ﹤0.01% 1013
2024
Q4 		$534K Sell
10,606
-54
-0.5% -$2.83K ﹤0.01% 1490
2024
Q3 		$493K Sell
10,660
-209
-2% -$7.43K ﹤0.01% 1535
2024
Q2 		$353K Buy
10,869
+62
+0.6% +$1.7K ﹤0.01% 1740
2024
Q1 		$272K Sell
10,807
-201
-2% -$4.75K ﹤0.01% 1954
2023
Q4 		$358K Buy
11,008
+2,432
+28% +$66.8K ﹤0.01% 1722
2023
Q3 		$234K Sell
8,576
-157
-2% -$4.54K ﹤0.01% 2003
2023
Q2 		$194K Buy
8,733
+1,025
+13% +$23.6K ﹤0.01% 2216
2023
Q1 		$167K Sell
7,708
-1,465
-16% -$32.1K ﹤0.01% 2256
2022
Q4 		$186K Buy
9,173
+231
+3% +$5.79K ﹤0.01% 2173
2022
Q3 		$228K Buy
8,942
+1,837
+26% +$49.2K ﹤0.01% 2002
2022
Q2 		$168K Buy
7,105
+298
+4% +$6.49K ﹤0.01% 2256
2022
Q1 		$154K Buy
6,807
+406
+6% +$8.64K ﹤0.01% 2430
2021
Q4 		$126K Sell
6,401
-635
-9% -$12.9K ﹤0.01% 2539
2021
Q3 		$139K Buy
7,036
+992
+16% +$20.8K ﹤0.01% 2415
2021
Q2 		$133K Sell
6,044
-540
-8% -$12K ﹤0.01% 2477
2021
Q1 		$158K Buy
6,584
+89
+1% +$2.38K ﹤0.01% 2320
2020
Q4 		$170K Buy
6,495
+402
+7% +$8.47K ﹤0.01% 2162
2020
Q3 		$105K Sell
6,093
-222
-4% -$3.54K ﹤0.01% 2299
2020
Q2 		$105K Buy
6,315
+419
+7% +$5.89K ﹤0.01% 2293
2020
Q1 		$70K Sell
5,896
-2,938
-33% -$36.4K ﹤0.01% 2433
2019
Q4 		$106K Sell
8,834
-116,717
-93% -$1.62M ﹤0.01% 2455
2019
Q3 		$1.77M Sell
125,551
-36,883
-23% -$453K ﹤0.01% 1034
2019
Q2 		$1.81M Sell
162,434
-48,087
-23% -$536K ﹤0.01% 1052
2019
Q1 		$2.47M Sell
210,521
-253,791
-55% -$3.15M ﹤0.01% 961
2018
Q4 		$6.2M Buy
464,312
+456,876
+6,144% +$6.04M 0.01% 615
2018
Q3 		$104K Sell
7,436
-67,594
-90% -$945K ﹤0.01% 2577
2018
Q2 		$1.18M Buy
75,030
+3,016
+4% +$52.5K ﹤0.01% 1255
2018
Q1 		$1.19M Sell
72,014
-213,351
-75% -$3.95M ﹤0.01% 1241
2017
Q4 		$5.15M Sell
285,365
-19,814
-6% -$359K 0.01% 724
2017
Q3 		$5.89M Buy
305,179
+295,342
+3,002% +$4.4M 0.01% 646
2017
Q2 		$116K Buy
9,837
+3,390
+53% +$36.8K ﹤0.01% 2435
2017
Q1 		$72K Buy
+6,447
New +$56.6K ﹤0.01% 2705
2016
Q3 		– Sell
-429
Closed -$2K – 4027
2016
Q2 		$2K Sell
429
-16
-4% -$83 ﹤0.01% 4138
2016
Q1 		$2K Buy
445
+15
+3% +$58 ﹤0.01% 4160
2015
Q4 		$2K Hold
430
– – ﹤0.01% 4145
2015
Q3 		$2K Buy
430
+14
+3% +$71 ﹤0.01% 4266
2015
Q2 		$3K Buy
416
+121
+41% +$742 ﹤0.01% 4251
2015
Q1 		$2K Buy
+295
New +$1.07K ﹤0.01% 4280

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PNC Financial Services Group's CORT Position: Q2 2026 in Review

PNC Financial Services Group increased its Corcept Therapeutics (CORT) stake by 17% in Q2 2026, buying an estimated $195K and bringing the position to 22,260 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

PNC Financial Services Group first reported a position in CORT in Q1 2015 and has held it in 44 quarters since. The position peaked at $6.2M in Q4 2018. 205 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • PNC Financial Services Group held 22,260 shares of Corcept Therapeutics worth $1.94M as of Q2 2026.
  • PNC Financial Services Group bought 3,230 Corcept Therapeutics shares in Q2 2026, an estimated $195K.
  • Corcept Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1074 holding.
  • PNC Financial Services Group first reported a position in Corcept Therapeutics in Q1 2015 and has held it in 44 quarters since.
  • PNC Financial Services Group's Corcept Therapeutics position peaked at $6.2M in Q4 2018.
  • 205 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.